Principal Investigator
Cynthia Levy
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250131
Clinical Trial Summary
APOLLO: A Randomized, Double-Blind, Placebo-Controlled Study of Bitopertin to Evaluate the Efficacy, Safety, and Tolerability in Participants with Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)
Phase
Phase III
Funding Agency/Sponsor
Industry
Disease
Erythropoietic protoporphyria (EPP)
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu